UCB SA (LON:0NZT)
London
· Delayed Price · Currency is GBP · Price in EUR 168.45
+1.55 (0.93%)
At close: Mar 28, 2025
UCB SA Revenue
In the year 2024, UCB SA had annual revenue of 6.15B EUR with 18.72% growth. UCB SA had revenue of 3.36B in the half year ending December 31, 2024.
Revenue
6.15B EUR
Revenue Growth
+18.72%
P/S Ratio
n/a
Revenue / Employee
656.00K EUR
Employees
9,378
Market Cap
25.87B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.15B | 970.00M | 18.72% |
| Dec 31, 2023 | 5.18B | -265.00M | -4.87% |
| Dec 31, 2022 | 5.45B | -330.00M | -5.71% |
| Dec 31, 2021 | 5.78B | 430.00M | 8.04% |
| Dec 31, 2020 | 5.35B | 434.00M | 8.83% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| Shell | 227.10B |
| HSBC Holdings | 48.93B |
| Unilever | 50.25B |
| Rio Tinto Group | 42.86B |
| RELX PLC | 9.43B |
| BP p.l.c. | 149.68B |
| British American Tobacco p.l.c. | 25.87B |